Electroconvulsive therapy (ECT) is one of the most effective treatments available for severe depression. In a decade-long national dataset from Scotland, 73% of patients with moderate to severe depression responded to ECT, and 51% achieved full remission. Those numbers hold up even in people whose depression hasn’t responded to medication, making ECT a uniquely powerful option when other treatments fall short.
Response Rates for Depression
The headline numbers for ECT in major depression are strong by any standard in psychiatry. A 73% response rate means nearly three out of four patients experience a meaningful reduction in symptoms. A 51% remission rate means roughly half reach a point where their depression is essentially gone, at least in the short term. For context, most antidepressant medications produce remission in about 30% of patients on a first trial.
For treatment-resistant depression, defined as cases where multiple medications have failed, ECT still achieves remission rates above 50%. That’s remarkable given that these patients have already proven difficult to treat. It’s one reason ECT is often described as the most effective intervention in all of psychiatry for severe, medication-resistant depression.
How ECT Compares to Ketamine
Ketamine infusions have gained attention as another option for hard-to-treat depression, so the comparison matters. A meta-analysis published in JAMA Psychiatry found that ECT outperformed ketamine on every major measure. Remission rates were 62.6% for ECT versus 46.3% for ketamine, a statistically significant difference. ECT also produced greater reductions in depression scores overall.
Ketamine does have one advantage: speed. Several studies found that ketamine produced faster antidepressant effects during the first few treatment sessions. But over the full course of treatment, ECT patients ultimately achieved better outcomes. If you’re weighing the two options, ECT appears to be the more effective treatment, while ketamine may offer quicker initial relief.
Effectiveness in Bipolar Depression
ECT isn’t limited to unipolar depression. In bipolar depression, the numbers are even more impressive. A study of over 1,200 patients found that 80.2% responded to ECT. Four out of five patients with bipolar depression improved significantly. This makes ECT one of the strongest tools available for bipolar depression, which is notoriously difficult to treat with medications alone.
The Relapse Problem
ECT’s biggest limitation isn’t how well it works in the short term. It’s how long the benefits last. A meta-analysis of modern studies found that among patients who responded to ECT and continued taking medication afterward, about 27% relapsed within three months. By six months, that number climbed to roughly 38%. By one year, about half had relapsed.
Most relapses happen in the first six months. Patients who were medication-resistant before ECT tend to relapse at higher rates than those who responded to medication in the past, which makes sense: if medications didn’t work well before ECT, they’re less likely to maintain the gains afterward. This is why many patients receive maintenance ECT, periodic sessions spaced weeks or months apart, to sustain the improvement.
Electrode Placement and Pulse Width Matter
Not all ECT protocols are equally effective. Two key variables are where the electrodes are placed and how the electrical pulse is shaped.
Right unilateral placement (electrodes on one side of the head) and bilateral placement (electrodes on both sides) produce similar reductions in depression when the dose is set appropriately. The advantage of right unilateral is cognitive: patients experience less confusion, fewer blood pressure disturbances, and better performance on memory tests afterward. For this reason, right unilateral ECT has become the more common starting approach.
Pulse width is a different story. Ultra-brief pulse ECT was developed to reduce cognitive side effects, and it does, but at a real cost to effectiveness. A recent meta-analysis found that ultra-brief pulse ECT achieved a remission rate of only 32.2% and a response rate of just 45.3%. More than a quarter of patients had to be switched to standard brief-pulse ECT because their response was inadequate. Standard brief-pulse remains the more reliable option.
Memory and Cognitive Side Effects
Memory loss is the side effect most people worry about, and it’s a legitimate concern. The most significant form is retrograde amnesia, difficulty recalling memories formed before treatment. With modern brief-pulse techniques, cognitive performance typically returns to baseline within about three days of a session. Retrograde amnesia mostly clears during the recovery period and is generally not detectable after three months.
That said, some patients do report persistent gaps in memory for events that occurred around the time of treatment. These gaps tend to be most noticeable for autobiographical memories, things like conversations, trips, or daily events, from the weeks surrounding ECT. The risk is lower with right unilateral electrode placement and brief-pulse (rather than ultra-brief or older sine-wave) stimulation.
How ECT Changes the Brain
The exact mechanism behind ECT’s effectiveness is still being pieced together, but one leading theory involves neuroplasticity. Animal studies show that electrical stimulation similar to ECT triggers the growth of new brain cells in the hippocampus, a brain region critical for mood regulation and memory. This process appears to be driven in part by a protein called BDNF, which supports the development, survival, and connection of neurons. Levels of this protein increase in the brain after electrical stimulation in animal models. Essentially, ECT may help the brain rewire itself in ways that break the patterns underlying severe depression.
What Patients Say About the Experience
Despite its reputation, patients who actually undergo ECT tend to view it favorably. In one study, 91% of patients who received ECT agreed with the statement “I am glad that I received ECT.” Patients who had direct experience with the treatment held significantly more positive attitudes toward it than patients who hadn’t received it. This gap between public perception and patient experience is one of the more striking things about ECT. The procedure itself is done under general anesthesia, lasts only a few minutes, and patients typically go home the same day.